Evolution of aminoglycoside resistance phenotypes of four Gram-negative bacteria: An 8-year survey in a University Hospital in Greece

International Journal of Antimicrobial Agents

Volumn 22, Issue 5, 2003, Pages 526-531

  Neonakis, I ^a   Gikas, A ^a   Scoulica, E ^a   Manios, A ^a   Georgiladakis, A ^a   Tselentis, Y ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Aminoglycoside; Gram negative bacteria; Phenotypes

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BACTERIAL ENZYME; GENTAMICIN; KANAMYCIN; NEOMYCIN; NETILMICIN; STREPTOMYCIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHEMICAL MODIFICATION; DIFFUSION; ENTEROBACTER AEROGENES; ENTEROBACTER AMNIGENUS; ENTEROBACTER CLOACAE; ENTEROBACTER SAKAZAKII; ENTEROBACTERIACEAE; ENZYME MODIFICATION; GENETIC VARIABILITY; GRAM NEGATIVE BACTERIUM; INCIDENCE; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; NONHUMAN; PANTOEA AGGLOMERANS; PHENOTYPE; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROTEUS PENNERI; PROTEUS VULGARIS; UNIVERSITY HOSPITAL; WILD TYPE;

EID: 0242290078     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(03)00152-3     Document Type: Article

References (23)

1. Mingeot-Leclerq M.P., Glupczynski Y., Tulkens P.M. Aminoglycosides: activity and resistance. Antimicrob. Agents Chemother. 43:1999;727-737.
2. Flamm R.K., Phillips K.L., Tenover F.C., Plorde J.J. A survey of clinical isolates of Enterobacteriaceae using a series of DNA probes for aminoglycoside resistance genes. Mol. Cell. Probes. 7:(2):1993;139-144.
3. Kettner M., Navarova J., Langsadl L. Aminoglycoside resistance patterns in clinical isolates of Enterobacteriaceae from Czechoslovakia. J. Antimicrob. Chemother. 20:(3):1987;383-387.
4. Courvalin P, Goldstein F, Philippon A, Sirot J. L′ Antibiogramme. Paris: Vigot, 1984.
5. Shaw K.J., Rather P.N., Hare R.S., Miller G.H. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol. Rev. 57:1993;138-163.
6. Le Goffic F., Martel A., Witchitz J. 3 N enzymatic acetylation of gentamicin, tobramycin, and kanamycin by Escherichia coli carrying R factor. Antimicrob. Agents Chemother. 6:1974;680-684.
7. Benveniste R., Davies J. Enzymatic acetylation of aminoglycoside antibiotics by Escherichia coli carrying an R factor. Biochemistry. 10:1971;1787-1796.
8. Benveniste R., Davies J. R-factor mediated gentamicin: a new enzyme which modifies aminoglycoside antibiotics. FEBS Lett. 10:1971;293-296.
9. Umezava H., Okanishi M., Kondo S., Hamana K., Utahara R., Maeda K., et al. Phosphorylative inactivation of aminoglycoside antibiotics by Escherichia coli carrying R factor. Science. 157:1967;1559-1561.
10. Chevereau M., Daniels P.J.L., Davies J., Le Goffic F. Aminoglycoside resistance in bacteria mediated by gentamicin acetyltransferase II, an enzyme modifying the 2′-aminogroup of aminoglycoside antibiotics. Biochemistry. 13:1974;598-603.
11. Witchitz J.L. Plasmid-mediated gentamicin resistance not associated with kanamycin resistance in Enterobacteriaceae. J. Antibiot. 25:1972;622-624.
12. Ozanne B., Benveniste R., Tipper D., Davies J. Aminoglycosides antibiotics: inactivation by phosphorylation in Escherichia coli carrying R factors. J. Bacteriol. 100:1969;1144-1146.
13. Miller G.H., Sabatelli F.J., Hare R.S., Glupczynski Y., Mackey P., Shlaes D., et al. The most frequent aminoglycoside resistance mechanisms - changes with time and geographic area: a reflection of aminoglycoside usage patterns? Clin. Infect. Dis. 24:(Suppl. 1):1997;S46-S62.
14. Miller G.H., Sabatelli F.J., Naples L., Hare R.S., Shaw K.J. The most frequently occurring aminoglycoside resistance mechanisms - combined results of surveys in eight regions of the world. J. Chemother. 7:(Suppl. 2):1995;17-30.
15. Mouton R.P., Glerum J.H., van Loenen A.C. Relationship between antibiotic consumption and frequency of antibiotic resistance of four pathogens - a seven-year survey. J. Antimicrob. Chemother. 2:1976;9-19.
16. Lambert HP. Clinical impact of drug resistance, J. Hosp. Infect. 1988;11(Suppl. A):135-41.
17. Phillips P. Environmental factors contributing to antibiotic resistance. Infect. Control. 4:1983;448-451.
18. Centrón D., Roy P.H. Characterization of the 6′-N- aminoglycoside acetyltransferase gene aac(6′)-Iq from the integron of a natural multiresistance plasmid. Antimicrob. Agents Chemother. 42:(6):1998;1506-1508.
19. Lévesque C., Piché L., Larose C., Roy P.H. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39:1995;185-191.
20. Tolmasky M.E., Crosa J.H. Genetic organization of antibiotic resistance genes (aac(6′)-Ib, aadA, and oxa9) in the multiresistance transposon Tn1331. Plasmid. 29:1993;31-40.
21. Centrón García D., Catalano M., Piñeiro S., Woloj M., Kaufman S., Sordelli D.O. The emergence of resistance to amikacin in Serratia marcescens isolates from patients with nosocomial infection. Int. J. Antimicrob. Agents. 7:1996;203-210.
22. Grogan J., Murphy H., Butler K. Extended-spectrum beta-lactamase- producing Klebsiella pneumoniae in a Dublin paediatric hospital. Br. J. Biomed. Sci. 55:(2):1998;111-117.
23. Levine J.F., Maslow M.J., Leibowitz R.E., et al. Amikacin-resistant Gram-negative bacilli: correlation of occurrence with amikacin use. J. Infect. Dis. 151:1985;295-300.